Plasma concentration of osimertinib in a non-small cell lung cancer patient with chronic renal failure undergoing hemodialysis

Lung Cancer. 2017 Oct:112:225-226. doi: 10.1016/j.lungcan.2017.07.007. Epub 2017 Jul 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acrylamides
  • Aniline Compounds
  • Carcinoma, Non-Small-Cell Lung / blood
  • Carcinoma, Non-Small-Cell Lung / complications
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / drug therapy*
  • Kidney Failure, Chronic / pathology
  • Piperazines / administration & dosage
  • Piperazines / blood*
  • Renal Dialysis / adverse effects

Substances

  • Acrylamides
  • Aniline Compounds
  • Piperazines
  • osimertinib